| Literature DB >> 36234762 |
Mehtap Sahiner1, A Sanem Yilmaz2, Buket Gungor3, Yasmin Ayoubi4, Nurettin Sahiner2,4,5.
Abstract
The prevalence of cardiovascular disease, oxidative stress-related complications, and chronic age-related illnesses is gradually increasing worldwide. Several causes include the ineffectiveness of medicinal treatment therapies, their toxicity, their inability to provide radical solutions in some diseases, and the necessity of multiple drug therapy in certain chronic diseases. It is therefore necessary for alternative treatment methods to be sought. In this review, polyphenols were identified and classified according to their chemical structure, and the sources of these polyphenol molecules are indicated. The cardioprotective, ROS scavenging, anti-aging, anticancer properties of polyphenolic compounds have been demonstrated by the results of many studies, and these natural antioxidant molecules are potential alternative therapeutic agents.Entities:
Keywords: anti-aging; atherosclerosis; cardioprotective; oxidative stress; reactive oxygen species
Mesh:
Substances:
Year: 2022 PMID: 36234762 PMCID: PMC9572829 DOI: 10.3390/molecules27196225
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Schematic presentation of classification of polyphenols.
Chemical structure of polyphenols and some examples of subgroups of polyphenols.
| Phenolic Acids | Flavonoids | Stilbenes | Lignans | |
|---|---|---|---|---|
| Hydrobenzoic acids | Hydroxycinnamic acids |
|
|
|
| gallic acid | caffeic acid | myricetin | resveratrol | podophyllotoxin |
| syringic acid | ferulic acid | catechin | rhapontigenin | secoisolariciresinol |
| tannic acid | coumaric acid | rutin | piceatannol | enterodiol |
| sinapinic acid | naringin | rhaponticin | sesamin | |
| rosmarinic acid | quercetin | oxyresveratrol | ||
Figure 2Schematic presentation of cardiovascular diseases and general factors involved in their pathology.
Some of the polyphenol efficacies, working concentration, and target of each substance on cardiovascular diseases.
| Study Design | Outcomes | Ref. |
|---|---|---|
| Caffeic acid (100 nM and 1 μM) human umbilical vein-derived endothelial cells (HUVEC) | Caffeic acid increased proliferation and angiogenesis, inhibited leukocyte adhesion and endothelial cell apoptosis under hypoxia or by the uremic toxins’ conditions | [ |
| Caffeic acid phenethyl ester (CAPE) 30 mg/kg/day administered by oral gavage for 6 weeks. Streptozotocin induced diabetes-induced atherosclerosis in rat model | CAPE abolished the diabetes-associated atherosclerotic changes by improving important functional and structural disorders in vessels. CAPE alleviated the elevation in systolic and diastolic BP | [ |
| High fructose (HFCS) induced diabetic rats’ subacute CAPE administrations (50 μmol/kg/day intraperitoneally for 2 weeks | CAPE ameliorated the elevation in blood pressure, vascular damage, and it increased eNOS levels. CAPE lowered homocysteine and cholesterol levels | [ |
| Atherogenic diet (Ath)-induced rat model administrations with caffeic acid 50 mg/kg, p.o. | CA ameliorated lipid profile and reduced the oxidative stress level. In aorta revealed reduction of the atherosclerotic lesions | [ |
| Dietary 10% flaxseed content 1.37 mg/g SDG, (the lignan secoisolariciresinol diglucoside) LDL receptor-deficient mouse (LDLrKO) fed a cholesterol-supplemented diet and an increase in atherosclerotic plaque formation | Flaxseed lowered plasma cholesterol levels and saturated fatty acids, increased plasma ALA levels, and inhibited plaque formation in the aorta and reduced the inflammatory markers (IL-6, mac-3, and VCAM-1) | [ |
| A 40 g/day of ground flaxseed administered Sixty-two men and post-menopausal women (LDL-C between 130 and 200) mg/dl 10 weeks | Flaxseed lowered LDL-C short lived and did not affect inflammation or oxidative stress | [ |
| Low-density lipoprotein receptor knockout (LDLR−/−) mice with 170 g/kg sesame oil diet 3 months of feeding | Reduced atherosclerotic lesion formation, plasma cholesterol, triglyceride, and LDL cholesterol levels. Anti-inflammatory property (reduced inflammatory cytokines, such as MCP-1, RANTES, IL-1a, IL-6, and CXCL-16) | [ |
| Sesamol 50 mg/kg orally for 6 weeks (DOCA)-salt-induced hypertensive rats | Decreased systolic and diastolic blood pressure and lipid peroxidation and enhanced the antioxidant activity. Hypertensive rats showed cardiac muscle fiber rupture and mononuclear infiltration, but Sesamol 50 mg/kg group heart showed to near-normal architecture | [ |
| Isoproterenol treated myocardial infarcted rats, pretreated with gallic acid (15 mg/kg) daily for a period of 10 days | Prevented the changes in the activities of cardiac marker enzymes (CK-MB and LDH), reduced the levels of lipid peroxidation products (LPO), glutathione and lysosomal membrane damage | [ |
| Rats were infused with AGEs (advanced glycation end products play a role development of cardiovascular disorders) and then treated with gallic acid (GA) by oral gavage daily at a dose of 25 mg/kg BW/day for 30 days | AGEs induced cardiac fibrosis and augmented oxidative stress in the heart tissues. GA prevented the upregulation of pro-fibrotic genes and ECM proteins (↓TNF-α, TGF-β, MMP-2 and -9 expression). GA treatment effectively prevented cardiac remodeling | [ |
| NG-nitro-L-arginine methyl ester (L-NAME)-induced hypertensive mice treatment with gallic acid 100 | GA attenuated cardiac fibrosis and remodeling, reduced the expression of histone deacetylase 1 (HDAC1) and 2 (HDAC2). GA lowered the elevated SBP | [ |
Figure 3Demonstration of the protective effects of natural products containing polyphenolics on cardiovascular system health.
Figure 4Reactive oxygen species (ROS) causing oxidative stress, oxidized low-density lipoprotein (OxLDL) and atherosclerotic plaque formation (adapted from ref. [129]).
Figure 5Removal of hydrogen, extinction of ROS, and formation of stabilized polyphenol radicals.
Some of the information regarding polyphenols efficacies, working concentration, and target of each substance on ROS-induced oxidative stress.
| Study Design | Outcomes | Ref. |
|---|---|---|
| A stock solution of resveratrol at a concentration of 200 mg/mL in human umbilical vein endothelial cell (HUVEC); cell culture study | When treated with resveratrol following administration to HUVECs ox LDL, it has been shown that resveratrol inhibits increased ROS formation and lipid peroxidation caused by ox-LDL and reduces SOD activity. Resveratrol effectively inhibited endothelial cell apoptosis through inhibition of mitochondrial pathway and inhibition of oxidative damage. It has been reported that resveratrol may be effective in the treatment of atherosclerosis | [ |
| Rosmarinic acid with antioxidant properties with different test methods | RA was determined 67.5 ± 1.68 (μg/mL). Total phenol content in terms of gallic acid equivalency, 1.62 ± 0.41 TEAC value (mM trolox equivalent/g), 806.7 ± 39.5 quercetin eq for total flavonoid test. It was specified 15 μg dry weight RA reduced 366.2 ± 9.9 μmol Fe (III) ions | [ |
| Administration of resveratrol 50 mg/mL to healthy rats in drinking water for 3 weeks | It shows that resveratrol can improve the capacity of endothelial function and oxidative stress under physiological conditions | [ |
| Prunan from prunes alleviates inflammation and oxidative stress during lithium/pilocarpine-induced epileptic seizures | Comparing 50 mg/kg b.w. pinoresinol-4-O-d-glucopyranoside to pilocarpine-treated animals, this compound reduced malondialdehyde levels by 24.2% and increased catalase activity by 44.4% | [ |
Some of the information regarding polyphenols efficacies, working concentration, and target of each substance on DNA and cancer.
| Study Design | Outcomes | Ref. |
|---|---|---|
| Naringin’s anti-tumor effects on thyroid cancer were studied. For 24, 48, or 72 h at 37 °C, Naringin (6, 12, and 25 g/mL) was applied to two cancer cells, TPC-1 and SW1736. | In MTT assays, naringin inhibited TPC-1 and SW1736 cell proliferation in a dose- and time-dependent manner. | [ |
| Naringin was combined with the drug, atorvastatin. | The IC50 of naringin was determined as 196.2 μM in PC-3 and 117.2 μM in LNCaP cells. However, naringin and statin drug atorvastatin synergistically inhibited prostate cancer cells, PC-3, and LNCaP cells. | [ |
| Catechin was studied on MC38 colon cancer cells. | The proliferation of cancer cells can be significantly inhibited by catechin concentrations between 250 and 1000 mg/mL, and the IC50 value is 250 mg/mL during a 24 h incubation period. Incubation time was 72 h, and IC50 was 142 mg/mL after triggering cancer cells. | [ |
| An anticancer effect of gallic acid on non-small cell lung cancer cells A549. | The viability of A549 cells was determined by MTT assay after treatment with GA (0–52 g/mL) for 24 h. There was a dose-dependent decrease in viability after treatment with GA (0–52 g/mL). When compared with control cells, 12 g/mL GA significantly decreased cell viability. | [ |